• Tags: cornea
Pandorum Tech raises $18M to expand operations for bioengineered cornea
Pipeline

Pandorum Tech raises $18M to expand operations for bioengineered cornea

Financing to advance biotech’s ‘liquid-based cornea’ Kuragenx, an eye drop bioengineered to revert an ulcerative cornea to its healthy state in less than 1 year.
WAVE Lens Designer Software integrates with Topcon MYAH
Products

WAVE Lens Designer Software integrates with Topcon MYAH

Integration enables direct import of corneal topography data into custom lens platform, streamlining the specialty contact lens design workflow.
FDA  approves Allotex's IDE for US study of tissue-based solution for presbyopia
Pipeline

FDA approves Allotex's IDE for US study of tissue-based solution for presbyopia

Company gets all-clear for clinical trial on its tissue addition technology and customized, laser-shaped human corneal tissue to restore vision.
OKYO Pharma reports favorable phase 2 data for NCP asset
Pipeline

OKYO Pharma reports favorable phase 2 data for NCP asset

Formerly OK-101, urcosimod is formulated for topical application, with latest results demonstrating a favorable impact on corneal nerve health.
EyeYon Medical secures IDE approval for study on first artificial endothelial layer
Pipeline

EyeYon Medical secures IDE approval for study on first artificial endothelial layer

IDE approval allows for clinical study initiation to evaluate EndoArt, the first-ever synthetic implant for treating corneal edema and improving vision.
Precise Bio performs first transplant with 3D-printed cornea implant
Pipeline

Precise Bio performs first transplant with 3D-printed cornea implant

Procedure deemed successful in treating first fully blind patient using corneal bio-implant made from corneal endothelial cells.
Study identifies key vitamin supplementation for NCP
Research

Study identifies key vitamin supplementation for NCP

Vitamins B3, 12, and D may offer new therapeutic approaches to neuropathic corneal pain management.
Nearly 50% of adults with keratoconus still facing high rate of progression
Research

Nearly 50% of adults with keratoconus still facing high rate of progression

Study finds, across all age groups, patients with advanced disease were most at risk of keratoconus progression.
Study: BioTissue's CAM improves recovery following corneal CXL
Research

Study: BioTissue's CAM improves recovery following corneal CXL

Research from AAO supports BioTissue’s Prokera as an FDA-cleared therapeutic device for use following epi-off CXL among keratoconus patients.
 Verséa Ophthalmics relaunches as DefEYE Inc
Business

Verséa Ophthalmics relaunches as DefEYE Inc

Ophthalmic biologics company makes official debut with the exclusive U.S. commercial rights to the BIOVANCE franchise of decellularized biologics.
Kala's phase 2b PCED trial fails to meet primary goal
Pipeline

Kala's phase 2b PCED trial fails to meet primary goal

Company plans to cease development of lead asset KPI-012 as the CHASE study also falls short of achieving statistical significance for secondary endpoints.
Are corneal dystrophies linked to mental health conditions?
Research

Are corneal dystrophies linked to mental health conditions?

Study highlights the importance of assessing corneal dystrophy patients’ psychological well-being.
FDA reportedly clears Moria Surgical's corneal storage solution
Products

FDA reportedly clears Moria Surgical's corneal storage solution

XTRA4 is designed to preserve refrigerated human donor corneas for up to 14 days—reducing risk for graft detachments and improving availability for corneal transplant patients.
Unique anterior stromal puncture device targets RCEs
Products

Unique anterior stromal puncture device targets RCEs

VEO Ophthalmics and Plexitome Medical’s partnership includes commerical launch of a new ASP method that allows treatment in the optical axis—without scarring.
Ziemer USA unveils new CTAK module for GALILEI diagnostic platform
Products

Ziemer USA unveils new CTAK module for GALILEI diagnostic platform

Latest addition to the FDA-cleared diagnostic device combines high-resolution corneal tomography with laser-guided stromal inlay preparation for customized corneal reshaping.
Haag-Streit launches corneal map for the Lenstar 900
Products

Haag-Streit launches corneal map for the Lenstar 900

The optical biometer’s newest integratable feature enables simultaneous measurement of a wider range of biometric parameters for cataract surgery planning.
Allotex submits IDE to FDA for collagen-based corneal implant
Pipeline

Allotex submits IDE to FDA for collagen-based corneal implant

Company is seeking to conduct a U.S. clinical trial on its tissue addition technology procedure that augments the cornea using precision-shaped human collagen.
ADHD medication may lead to corneal cell changes in pediatric patients
Research

ADHD medication may lead to corneal cell changes in pediatric patients

Study notes differences in key parameters of corneal and retinal health in patients taking methylphenidate.
Allotex names new CEO to lead commercialization of allogeneic corneal tissue technology
Business

Allotex names new CEO to lead commercialization of allogeneic corneal tissue technology

Co-founder Michael Mrochen, PhD, will assume leadership as the startup seeks an IDE for its biocompatible procedure for vision correction.
B+L launches Zenlens CHROMA HOA scleral contact lenses
Products

B+L launches Zenlens CHROMA HOA scleral contact lenses

Newest addition to the scleral lens brand features a custom-designed, wavefront-guided scleral lens technology intended to correct advanced HOA.